NEW YORK, Jan. 31, 2019 (GLOBE NEWSWIRE) -- via
CannabisNewsWire â CannabisNewsWire
("CNW"), a multifaceted financial news and publishing company,
today announces the publication of an editorial featuring Lexaria Bioscience Corp.
(CSE:LXX) (LXRP), a client of CNW
focused on licensing disruptive patented delivery technology that
promotes healthier ingestion methods, lower overall dosing and
quicker onset of lipophilic active molecules.
To view the full publication, titled âOutside Investment, New Technology Support Growing Cannabis Industry,â visit: http://cnw.fm/H3q7r
Lexaria Bioscience Corp. (CSE:LXX) (LXRP) is an example of one company that has built a big funding deal on its own terms.
Biotech company Lexaria is perhaps most known for its DehydraTECH technology, a revolutionary system for processing molecular compounds to make them more suitable for human consumption. Applicable to molecules such as THC and cannabidiol, the active ingredients in cannabis, the technology makes these compounds taste better, increases the bodyâs ability to absorb them, and speeds up their impact on the body. Together, these changes can increase the efficacy of both medical and recreational drugs.
About Lexaria Bioscience Corp.
Lexaria Bioscience has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and quicker onset of lipophilic active molecules. Lexaria has ten patents granted in the United States and Australia, and has filed over 50 patent applications worldwide across 10 patent families. Lexariaâs technology provides more rapid delivery to the bloodstream, as well as important taste-masking benefits for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the companyâs website at www.LexariaBioscience.com.
About CannabisNewsWire
(CNW)
CannabisNewsWire (âCNWâ) is a specialized information service that
(1) aggregates cannabis news, (2) provides CannabisNewsBreaks that
quickly updates investors in the space, (3) enhances corporate
press releases, (4) helps companies with distribution and
optimization of social media, and (5) delivers comprehensive
corporate communication solutions. CNW is uniquely positioned in
the cannabis market with a strong team of journalists and writers
who can help private and public companies reach a wide audience of
investors, consumers, journalists and the general public through
our ever-growing dissemination network of more than 5,000 key
syndication outlets. CNW is bringing unparalleled visibility,
recognition and content to the cannabis industry.
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the
CannabisNewsWire website applicable to all content provided by CNW,
wherever published or re-published: http://CNW.fm/Disclaimer
Forward-Looking Statements
This release contains forward-looking statements within the meaning
of Section 27A of the Securities Act of 1933, as amended and
Section 21E of the Securities Exchange Act of 1934, as amended. All
forward-looking statements are inherently uncertain as they are
based on current expectations and assumptions concerning future
events or future performance of the company. Readers are cautioned
not to place undue reliance on these forward-looking statements,
which are only predictions and speak only as of the date hereof. In
evaluating such statements, prospective investors should review
carefully various risks and uncertainties identified in this
release and matters set in the company's SEC filings. These risks
and uncertainties could cause the company's actual results to
differ materially from those indicated in the forward-looking
statements.
CNW Corporate Communications Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]